|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at UBS Warburg Global Healthcare Services Conference|
BOULDER, Colo., Jan. 21 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Warburg Global Healthcare Services Conference on February 5 in New York City. The public is welcome to participate in the conference through an audio webcast on the UBS Warburg website.
Date: Wednesday, February 5, 2003
Audio Webcast: www.ubswarburg.com
To access the audio webcast, go to www.ubswarburg.com and click on the UBS Warburg conference link found on the lower right side of the page. Follow the link for Webcast under the Global Healthcare Services Conference heading. The presentation will be available live and by replay. The replay will begin three hours after the presentation time and will be available until March 5, 2003.
About Array BioPharma:
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com . SOURCE Array BioPharma Inc.
/CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org/
/Web site: http://www.arraybiopharma.com